Clinical Study

Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back

Figure 2

Change in individual endometrioma volumes. Mean endometrioma volume decreased 75% from 60.1 cm3 to 15.0 cm3 with 3 months of aromatase inhibition plus progestin add-back.